Teriparatide biosimilar (Theramex)

特立帕肽生物类似药(Theramex)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTeriparatide biosimilar (Theramex)
Drug Alias NameLivogiva
ClassificationBiologics > Protein drugs > Recombinant polypeptideBiologics > Biosimilar
Mechanisms of ActionParathyroid hormone replacements
TargetsParathyroid hormone receptor
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsOsteoporosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2020/08/27
Country/TerritoryEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTheramex Ireland Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTheramex Ireland Ltd
Inactive CompaniesN/A
Active IndicationsOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeH05AA02
Related LinksN/A